Related Experiment Video
Updated: Jan 30, 2026

Liver Cold Storage and Transplantation in the Cold-Adaptive Daurian Ground Squirrels
Published on: July 3, 2025
Understanding and managing cardiovascular outcomes in liver transplant recipients
Manhal Izzy1, Lisa B VanWagner2, Samuel S Lee3
1Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University School of Medicine, Nashville, Tennessee.
Insights
Cardiovascular disease (CVD) is a leading cause of death post-liver transplant. Effective management requires addressing pre-transplant conditions and adopting comprehensive strategies for prevention and treatment.
Area of Science:
- Transplantation Medicine
- Cardiology
- Hepatology
Background:
- Cardiovascular disease (CVD) is a significant cause of mortality in liver transplant recipients.
- CVD is the primary cause of death within the first year following liver transplantation.
- Pre-transplant diastolic dysfunction, indicative of cirrhotic cardiomyopathy, is a key cardiovascular concern.
Purpose of the Study:
- To review the prevalence, precipitating factors, and management strategies for CVD in liver transplant recipients.
- To emphasize the importance of understanding CVD in improving long-term survival after liver transplantation.
- To highlight the need for comprehensive prevention and treatment approaches for cardiovascular complications.
Main Methods:
- Review of current literature on cardiovascular disease in liver transplant recipients.
- Analysis of precipitating factors including pre-transplant diastolic dysfunction and cirrhotic cardiomyopathy.
- Evaluation of existing and proposed prevention and management strategies.
Main Results:
- Arrhythmia and heart failure are common morbidities in the first year post-transplant, linked to pre-transplant diastolic dysfunction.
- Cardiovascular risk prediction models are increasingly available for managing liver transplant recipients.
- Metabolic syndrome and weight management are crucial for CVD prevention.
Conclusions:
- A comprehensive strategy including weight management and metabolic syndrome control is vital for minimizing CVD morbidity and mortality.
- Utilizing 'metabolic-friendly' immunosuppressive regimens and adhering to established cardiology/endocrine guidelines are recommended.
- Bariatric surgery represents an underutilized option for managing metabolic derangements in this population.
Purpose Of Review:
Cardiovascular disease (CVD) is a common cause of mortality after liver transplantation. The transplant community is focused on improving long-term survival. Understanding the prevalence of CVD in liver transplant recipients, precipitating factors as well as prevention and management strategies is essential to achieving this goal.
Recent Findings:
CVD is the leading cause of death within the first year after transplant. Arrhythmia and heart failure are the most often cardiovascular morbidities in the first year after transplant which could be related to pretransplant diastolic dysfunction. Pretransplant diastolic dysfunction is reflective of presence of cirrhotic cardiomyopathy which is not as harmless as it was thought. Multiple cardiovascular risk prediction models have become available to aid management in liver transplant recipients.
Summary:
A comprehensive prevention and treatment strategy is critical to minimize cardiovascular morbidity and mortality after liver transplant. Weight management and metabolic syndrome control are cornerstones to any prevention and management strategy. Bariatric surgery is an underutilized tool in liver transplant recipients. Awareness of 'metabolic-friendly' immunosuppressive regimens should be sought. Strict adherence to the cardiology and endocrine society guidelines with regard to managing metabolic derangements post liver transplantation is instrumental for CVD prevention until transplant specific recommendations can be made.
Related Concept Videos
Kidney Transplant III: Nursing Management
Understanding the Self
Predicting Reaction Outcomes
Understanding Self-Concept
Understanding Deception
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...

